| Nature Biotechnology Nature Biotechnology is the premier peer-reviewed monthly of biotechnology, providing reviews and research reports on the research and technologies that drive biotechnological innovation wherever they are applied – in the biotechnology, pharmaceutical, agricultural and environmental industries. With an impact factor of 12.822*, Nature Biotechnology is rated number one among primary journals in its field. Simply visit www.nature.com/naturebiotechnology for more information. *Thomson ISI, PA, USA, 2002 |
 |
| Nature Reviews Drug Discovery Nature Reviews Drug Discovery is a monthly review journal that publishes authoritative, peer-reviewed articles by leaders in the field – providing a complete overview of the drug discovery and development arena, from disease mechanisms and chemistry, through to clinical development and regulatory issues. The journal, which integrates academia and industry, features cutting edge Review articles, Highlights of the latest primary papers, as well as Opinion articles and historical Perspectives. For more information simply visit www.nature.com/reviews/drugdisc
|
 |
| BioCommerce Data Ltd Published in print, CD-ROM and electronically the guides cover:
Each compendium contains:
Available separately or as a complete set, in a number of formats. Also available: The Biotechnology Managers Mailing Lists
For more information on any of the products visit |
 |
| BioSpace, Inc. BioSpace, Inc. is a specialized provider of web-based products and information services to the life sciences. The company’s premier Website, www.biospace.com is the Internet’s most comprehensive life sciences-related information and service resource, attracting 800,000 unique visitors and over 4 million page views monthly. Recognizing the tidal wave of information being published in the life sciences, BioSpace has developed products and services that more efficiently deliver information in a context that is relevant to the end user. Offered both on the Internet, or an enterprise Intranet, BioSpace’s suite of Enterprise Portal Services includes an information management tool called BioSpace LInKS™ Solution, and CCIS, a Clinical Competitive Intelligence System. Additionally the company leverages its extensive online community to offer highly popular life sciences industry Career Fairs. San Francisco-based BioSpace.com was launched in 1995. |
 |
| Biotechnology Investment Today Biotechnology Investment Today is a quarterly review journal for stakeholders in the biotechnology industry. The magazine covers therapeutic and technology sectors within the industry as well as critical operational and financing issues that directly affect company and shareholder value. Topics covered in recent issues include: Cancer Therapeutics, Pharmacogenomics, M&A, Capital Markets and Pathways to Market. The magazine also covers emerging markets and in 2002 will review Australia, Israel, Singapore and Japan. Biotechnology Investment Today is supported by a global seminar and investor network series with events held regularly in the US and Europe. |
 |
| www.biotext.co.uk
Biotext is the exciting new online service from ICP Europe Publishing plc (if possible link to www.icpeurope.net) providing information and services to participants in the market where the biotechnology and finance communities overlap. As well as daily biotech finance news and features, Biotext also offers complimentary subscription to its established monthly e-mail newsletter 'TranScript'. Biotext and TranScript are packed with:
The TranScript newsletter was established in early 2002 and is now read by over 15,000 industry figures, to subscribe please visit www.biotext.co.uk For more information about Biotext please contact Emma Kettle via ekettle@icpeurope.net or +44 (0)20 7961 0339. |
 |
| BioVenture View BioVenture View is the definitive twice-monthly newsletter for the global biotechnology industry and has been providing senior executives with the information they need to stay ahead of the competition. Each monthly issue provides an informative and incisive package of analysis and data, including:
|
 |
| BioWorld Today BioWorld Today, the newspaper of record for the biotechnology industry, is read by thousands of biotechnology professionals worldwide for its hard-hitting, objective news reporting. BioWorld Today is delivered by fax and e-mail every business morning, and is also found exclusively online at www.BioWorld.com. The BioWorld Online web site has been internationally recognized as the most comprehensive resource for strategic biotechnology news and information available today. In addition to original daily news reporting, BioWorld offers an extensive searchable database with more than 11 years of biotechnology archives. This site is not only a great source for insightful, up-to-the-minute news coverage, but a veritable library of information on the developments of the industry as well. With a quick search, BioWorld subscribers have instant access to a wealth of biotechnology market intelligence from every biotech hotspot around the globe. BioWorld does not post press releases, but rather uses information that is researched and written by the top business and science reporters in the industry. With nearly 20 writers spread throughout eight countries, BioWorld covers news on public companies and hard-to-find information on private companies. Our seasoned reporters get the inside scoop on what’s happening within the corporate walls, on regulatory issues in Washington and elsewhere, and on scientific breakthroughs worldwide. This news coverage of the biotechnology industry is 100% original and only available at BioWorld! BioWorld Products:
|
 |
| BusinessWire Business Wire disseminates full-text news announcements from thousands of companies and organizations worldwide to news media, financial markets, disclosure systems, investors, information web sites, databases and other audiences. Our BioWire2K circuits, developed by Business Wire in conjunction with Mary Ann Liebert, Inc., publisher of Genetic Engineering News and authoritative peer-reviewed journals, provides expertise, unparalleled contacts and proprietary databases to ensure that your industry news reaches key biotech media around the globe. |
 |
| Finance Finance is a monthly from two of the leading German publishing houses, Frankfurter Allgemeine Zeitung and manager magazin. FINANCE is the first authoritative publication on all aspects of the corporate finance market in Germany. Editorial topics are mergers and acquisitions, venture capital, going public, buy-outs and private equity. FINANCE particularly emphasizes the German medium-sized and start-up company sector. The guaranteed circulation is 25,000 copies a month. For subscription please call +49 40 3007 25 34, or fax +49 40 3007 3070. |
 |
| GoingPublic Media AG Founded in 1998 GoingPublic Media AG is today one of the leading companies in Germany publishing magazines on venture capital and corporate finance contents as well as small and mid cap research. In addition to the monthly issued GoingPublic Magazin and its well known yearly special editions like “Corporate Finance & Private Equity Guide”, “Biotechnology “or “Investor Relations” which are largely meant as reference books, the company publishes the likewise monthly VentureCapital Magazin. Founded in 2000 as a supplement to the GoingPublic Magazin, VentureCapital Magazin (www.venturecapital.de) started into a new era as an independent publication in July 2002 and focuses on private equity, buy-outs and M&A. The brand is a synonym for growth, innovation, entrepreneurial culture and equity financing. Special topics are additionally treated in supplements and special editions (“Nanotechnology”, “Mittelstandsfinanzierung” etc). Furthermore GoingPublic Media operates the online-service GoingPublic Online (www.goingpublic.de) and the corporate publishing division (GoingPublic Services) publishes about 10 magazines and newsletters a year for well-known venture capital companies and financial institutions. Since May 2003 the company publishes a third magazine called “Smart Investor” (www.smartinvestor.de). With its critical research and independent thinking, Smart Investor is an ambitious, fast growing magazine for the contrarian investor seeking information beyond the mainstream. All publications are printed in German. Contact: Orders and subscriptions: For more information, please contact us at +49-8171-419650 |
 |
LifeSci Channel – Tomorrow's Science Today The Broadcasting Division of Prous Science, headquarted in Barcelona, officially launched the LifeSci Channel, on October 27th, 2003, a Life Sciences information channel which is accessible via either traditional or advanced Internet, the latter of which provides television quality broadcasting. The channel provides peer-reviewed programming and information on the very latest in Life Sciences, directly into the workplace. Hundreds of hours of conferences, talks, news, interviews and presentations from around the world will be continuously broadcast and indexed in a single digital online library. Utilizing MAVS (Multilingual AudioVisual Search), a unique patented software, which allows for the first time instant retrieval of what you wish to hear and view from within a vast quantity of archived multimedia broadcasts. The LifeSci Channel is working with organizations such as the FDA, the American Heart Association and the Society for Medical Research (SMR), and has over 16 hours of exclusive footage from the 9th FDA Annual Science Forum, hosted in April. Regular program strands on the channel include the weekly series “Targets for Potential New Drugs”, “News This Week”, and “Inside the Pharma / Biotech Industry”, with other programs in development including “Inside Academia”. “Inside the Pharma / Biotech Industry” provides vital information with interviews and reports from key analysts, and brings together working professionals in public and private Life Science companies, along with Venture Capitalists, Investors, Business Development Officers and Corporate Executives. It offers the opportunity for companies to increase their profile and identify themselves as industry leaders. The LifeSci Channel is the ideal method for presenting a company and it’s unique technology platform to a direct target audience, outside of the traditional printed press release format. The presentations will be disseminated on a global scale on “Inside the Pharma / Biotech Industry”, the LifeSci Channel’s newest stream of programming. About Prous Science Contact: |
 |
Pharmaprojects
– Pharmaprojects is the premier source of business-critical
intelligence on drugs in global R&D providing users with a comprehensive
and accurate view of drug development. Pharmaprojects tracks every
significant new drug under development and contains analyses on
some 30000 drug candidates and 218 therapeutic areas investigated
since 1980, enabling users to: Committed to providing up-to-date intelligence, our editorial team of 20 scientists gathers and researches worldwide R&D information from sources including international scientific journals; conferences; stock brokerage and annual reports; company websites; press releases; online news agencies, and via continuous two-way communication with our company contacts. For a free trial or more information on our newly-launched Pharmaprojects on the Web, please contact Richard Collins on richard.collins@pjbpubs.com or telephone +44 (0) 20 8410 2840. Alternatively, visit www.pharmaprojects.com for more details. |
 |
| Scrip Reports Scrip Reports provide the highest standard of focused business intelligence in the pharmaceutical and biotechnology industries. Titles cover regulatory affairs, e-commerce, strategic management issues, therapeutics, drug discovery and biotechnology. We would like take this opportunity to introduce
you to two biotechnology business reports:- Scrip’s management guide, Proteomics Made Simple,
gives a jargon-free explanation of proteomics, its role within drug
discovery, the companies developing technologies and the strategies
adopted by big pharma. Use this easy-to-read guide to answer the
following questions:- ONLY £295/$620/¥71,000 REF: BS1225SACHS Did you know that nearly a third of new products are developed through pharma/biotech alliances? Scrip’s strategic management report entitled,
Biotech Alliances: Bridging the R&D gap will equip you with
reviews of the major factors influencing the growing relationship
between biotech and pharma, including: PRICE: £995/$2,090/¥239,000 REF: BS1211SACHS ***SPECIAL OFFER*** For more information please visit our website: www.scripreports.com or contact Rachael Hampton, Customer Relations on + 44 (0) 20 8332 8965/6, or rachael.hampton@pjbpubs.com. |
 |